Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

infectious disease
<em>Wolbachia</em>-Infected Mosquitoes Stymie Dengue&rsquo;s Spread: Study
Wolbachia-Infected Mosquitoes Stymie Dengue’s Spread: Study
Shawna Williams | Jun 10, 2021
Randomized, controlled research conducted in an Indonesian city confirms the reduction in cases seen with previous observational work.
The Psychology of Panic
The Psychology of Panic
Bob Grant | Jun 1, 2021
The recent news of consumers hoarding gasoline in the face of a brief closure of one of the world’s biggest petroleum pipelines is just the latest episode of panic buying since the COVID-19 pandemic started.
Contributors
Contributors
The Scientist Staff | Jun 1, 2021
Meet some of the people featured in the June 2021 issue of The Scientist.
Opinion: Comparing Coronaviruses
Opinion: Comparing Coronaviruses
Nicola Petrosillo | Jun 1, 2021
In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
Technique Talk: ELISA Tips and Tricks
Technique Talk: ELISA Tips and Tricks
The Scientist Creative Services Team | May 14, 2021
Learn to optimize ELISA experiments in this workshop.
Rare Fungal Infection Affecting COVID-19 Patients in India
Rare Fungal Infection Affecting COVID-19 Patients in India
Kerry Grens | May 11, 2021
Doctors are reporting an uptick in cases of a highly lethal condition called mucormycosis that might be linked to steroid treatments for SARS-CoV-2.
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
The Scientist Creative Services Team in collaboration with MilliporeSigma | May 10, 2021
Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.
Amanda Tokash-Peters Links the Microbiome to Ecology
Amanda Tokash-Peters Links the Microbiome to Ecology
Shawna Williams | May 1, 2021
The Centenary University professor studies the far-reaching effects of changes in the gut bacteria of mosquitos and other species.
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Catherine Offord | Apr 26, 2021
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.
Doctors Investigate Several Stillbirths Among Moms with COVID-19
Doctors Investigate Several Stillbirths Among Moms with COVID-19
Anthony King | Apr 23, 2021
After a handful of cases in Ireland, clinicians there are warning that the virus might infect the placenta in very rare instances and cause fetal distress, but a rise in stillbirths has not been seen in epidemiological studies.
Pharma, US Government Plan for COVID-19 Booster Shots
Pharma, US Government Plan for COVID-19 Booster Shots
Jef Akst | Apr 16, 2021
It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.
Q&amp;A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Jef Akst | Apr 9, 2021
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
How Infectious Diseases Affect the Brain
How Infectious Diseases Affect the Brain
The Scientist Creative Services Team | Apr 8, 2021
From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Q&amp;A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Fast-Tracking COVID-19 Research
Fast-Tracking COVID-19 Research
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 17, 2021
Identifying molecular targets for SARS-CoV-2 therapeutics.
Disease-Carrying Mosquito Species Returns to Florida
Disease-Carrying Mosquito Species Returns to Florida
Shawna Williams | Mar 17, 2021
Aedes scapularis is already established on the peninsula, and researchers predict that its population will continue to spread.